Samjin Pharm Asset Resilience Ratio

Latest as of September 2025: 0.25%

Samjin Pharm asset resilience ratio. Samjin Pharm (005500) has an Asset Resilience Ratio of 0.25% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Samjin Pharm defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩1.11 Billion

≈ $752.23K USD Cash + Short-term Investments

Total Assets

₩449.14 Billion

≈ $304.37 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Samjin Pharm (2013–2024)

Asset resilience ratio of Samjin Pharm from 2013 to 2024. This chart shows how Samjin Pharm's Asset Resilience Ratio has changed over time. Read 005500 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Samjin Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Samjin Pharm.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩1.11 Billion	0.25%
Total Liquid Assets	₩1.11 Billion	0.25%

Asset Resilience Insights

Limited Liquidity: Samjin Pharm maintains only 0.25% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Samjin Pharm Industry Peers by Asset Resilience Ratio

Compare Samjin Pharm's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	29.37%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Shenzhen Chipscreen Biosciences Co SHG:688321	Drug Manufacturers - Specialty & Generic	5.10%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
HPGC Renmintongtai Pharmaceutical Corp SHG:600829	Drug Manufacturers - Specialty & Generic	0.00%

Samjin Pharm Asset Resilience Ratio by Year (2013–2024)

Samjin Pharm asset resilience ratio by year from 2013 to 2024. The table below shows the annual Asset Resilience Ratio data for Samjin Pharm.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.07%	₩287.63 Million ≈ $194.92K	₩425.17 Billion ≈ $288.13 Million	-0.31pp
2023-12-31	0.38%	₩1.60 Billion ≈ $1.09 Million	₩419.90 Billion ≈ $284.56 Million	-0.19pp
2022-12-31	0.57%	₩2.32 Billion ≈ $1.57 Million	₩406.56 Billion ≈ $275.52 Million	-0.56pp
2021-12-31	1.13%	₩3.77 Billion ≈ $2.55 Million	₩332.50 Billion ≈ $225.33 Million	-0.94pp
2020-12-31	2.07%	₩5.58 Billion ≈ $3.78 Million	₩269.03 Billion ≈ $182.32 Million	-0.13pp
2019-12-31	2.21%	₩5.39 Billion ≈ $3.65 Million	₩244.15 Billion ≈ $165.46 Million	+0.35pp
2018-12-31	1.86%	₩4.66 Billion ≈ $3.15 Million	₩250.27 Billion ≈ $169.61 Million	-0.83pp
2017-12-31	2.69%	₩6.50 Billion ≈ $4.40 Million	₩241.85 Billion ≈ $163.90 Million	-0.44pp
2016-12-31	3.13%	₩7.12 Billion ≈ $4.83 Million	₩227.57 Billion ≈ $154.22 Million	+1.37pp
2015-12-31	1.76%	₩3.89 Billion ≈ $2.64 Million	₩220.74 Billion ≈ $149.59 Million	+0.09pp
2014-12-31	1.67%	₩3.50 Billion ≈ $2.37 Million	₩209.31 Billion ≈ $141.84 Million	-0.96pp
2013-12-31	2.63%	₩5.37 Billion ≈ $3.64 Million	₩203.95 Billion ≈ $138.21 Million	--

pp = percentage points

About Samjin Pharm

KO:005500 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$169.88 Million

₩250.67 Billion KRW

Market Cap Rank

#16933 Global

#634 in Korea

Share Price

₩20450.00

Change (1 day)

+0.49%

52-Week Range

₩17010.00 - ₩24700.00

All Time High

₩50479.08